26 May 2017
(MENAFN) UAE-based Julphar Gulf Pharmaceutical Industries, a pioneering pharmaceutical producer in the MENA region has recorded sales reaching USD100.5mn in Q1 of this year.
Furthermore, the board of the firm discussed and reviewed the development of the firm’s Vision 2020.
By 2020, the firm plans to reach more than USD544.4mn sales and rank amid the major three pharmaceutical firms in the country and in Saudi Arabia.
However, despite challenging market situations and the whole regional situation that are impacting the industry, the firm is considering its market share for the cited period.
MENAFN2605201700450000ID1095512067
MENAFN2605201700450000ID1095512067
05 Aug 2024
With the support of BBK, BIBF and BJA hold a graduation ceremony for journalists completing the training program
09 Jun 2024
BBK Successfully Closes USD Benchmark Bond Offering at $500 Million, in Collaboration with a Consortium of Regional and International Banks.
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more